Skip to main content
Loading ResearchHub…
Cited by — Efficacy of Taletrectinib (AB-106/DS-6051b) in ROS1+ NSCLC: An Updated Pooled Analysis of U.S. and Japan Phase 1 Studies | ResearchHub - ResearchHub